Elevated FTO mRNA expression is detected in peripheral blood samples from type 2 diabetic patients, resulting in decreased m6A content and disturbed glucose metabolism (Shen et al, 2015; Yang et al, 2019). The gene discussed is FTO; the disease is type 2 diabetes mellitus.